JP2006508099A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508099A5
JP2006508099A5 JP2004548934A JP2004548934A JP2006508099A5 JP 2006508099 A5 JP2006508099 A5 JP 2006508099A5 JP 2004548934 A JP2004548934 A JP 2004548934A JP 2004548934 A JP2004548934 A JP 2004548934A JP 2006508099 A5 JP2006508099 A5 JP 2006508099A5
Authority
JP
Japan
Prior art keywords
cpn10
animal
derivative
effective amount
pharmaceutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004548934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508099A (ja
JP4716731B2 (ja
Filing date
Publication date
Priority claimed from AU2002952492A external-priority patent/AU2002952492A0/en
Application filed filed Critical
Publication of JP2006508099A publication Critical patent/JP2006508099A/ja
Publication of JP2006508099A5 publication Critical patent/JP2006508099A5/ja
Application granted granted Critical
Publication of JP4716731B2 publication Critical patent/JP4716731B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004548934A 2002-11-06 2003-11-06 シャペロニン10免疫抑制 Expired - Fee Related JP4716731B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
AU2002952492 2002-11-06
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010286005A Division JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Publications (3)

Publication Number Publication Date
JP2006508099A JP2006508099A (ja) 2006-03-09
JP2006508099A5 true JP2006508099A5 (cg-RX-API-DMAC7.html) 2007-04-12
JP4716731B2 JP4716731B2 (ja) 2011-07-06

Family

ID=28795882

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004548934A Expired - Fee Related JP4716731B2 (ja) 2002-11-06 2003-11-06 シャペロニン10免疫抑制
JP2010286005A Pending JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010286005A Pending JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Country Status (16)

Country Link
US (3) US7618935B2 (cg-RX-API-DMAC7.html)
EP (3) EP1569679B1 (cg-RX-API-DMAC7.html)
JP (2) JP4716731B2 (cg-RX-API-DMAC7.html)
KR (1) KR101088740B1 (cg-RX-API-DMAC7.html)
CN (1) CN100525832C (cg-RX-API-DMAC7.html)
AT (1) ATE489963T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002952492A0 (cg-RX-API-DMAC7.html)
CA (1) CA2505141C (cg-RX-API-DMAC7.html)
CY (1) CY1110972T1 (cg-RX-API-DMAC7.html)
DE (1) DE60335202D1 (cg-RX-API-DMAC7.html)
DK (1) DK1569679T3 (cg-RX-API-DMAC7.html)
ES (1) ES2351993T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ540433A (cg-RX-API-DMAC7.html)
PT (1) PT1569679E (cg-RX-API-DMAC7.html)
SI (1) SI1569679T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004041300A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548985A (en) * 2004-01-16 2010-02-26 Cbio Ltd Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
CA2614480A1 (en) * 2005-07-11 2007-01-18 Cbio Limited Chaperonin 10-induced immunomodulation
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
WO2007025343A1 (en) 2005-08-31 2007-03-08 Cbio Limited Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CN101330922A (zh) * 2005-10-20 2008-12-24 悉生物有限公司 超敏的治疗
KR20090003310A (ko) 2006-03-02 2009-01-09 씨바이오 리미티드 항원 제시 세포의 기능 조절에 의한 면역 반응의 조절
RU2010145972A (ru) * 2008-04-11 2012-05-20 СиБАЙО ЛИМИТЕД (AU) МОДИФИЦИРОВАННЫЙ Cpn10 И ПЕРЕДАЧА СИГНАЛА PRR
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
KR102239867B1 (ko) 2012-12-10 2021-04-13 앨러간 파마슈티컬스 인터내셔널 리미티드 확장 가능한 3-차원 탄성 구조물 제조
CA2920312C (en) 2013-08-13 2022-07-19 Elastagen Pty Ltd Regeneration of damaged tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
EP0733071A4 (en) * 1993-11-30 1997-02-26 Univ Queensland ANTAGONISTS OF CHAPERONINE 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
WO1997005896A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
CA2383213A1 (en) * 1999-09-10 2001-03-15 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Similar Documents

Publication Publication Date Title
JP2006508099A5 (cg-RX-API-DMAC7.html)
CN111093708B (zh) 生物正交组合物
US7420033B2 (en) Composition of lactoferrin related peptides and uses thereof
US8454967B2 (en) Compositions and methods for modulating the immune system
TW200524626A (en) Treatment of HCV disorders
CN105073110B (zh) 通过诱导分化成调节性t细胞和促进调节性t细胞增殖来抑制免疫应答的药物组合物
JPH1180026A (ja) 新規免疫抑制剤、その使用方法およびその同定方法
US20250152665A1 (en) Mutant Peptides And Methods Of Treating Subjects Using The Same
JP5758806B2 (ja) シクロウンデカデプシペプチド化合物および医薬としてのその化合物の使用
CA2505141A1 (en) Chaperonin 10 immunosuppression
Siemionow et al. Advances in composite tissue allograft transplantation as related to the hand and upper extremity
JP2017529396A (ja) 急性放射線症候群を治療するための組成物及び方法
JP2023541403A (ja) ビオチンをミトコンドリアに送達するための方法及び組成物
CN1997384A (zh) 使用补体C5a受体调节剂治疗神经系统病症
Hogan et al. Use of cyclosporine in hematopoietic cell transplantation
JP4914008B2 (ja) 免疫寛容を誘導するためのジアミド誘導体と免疫抑制剤との組み合わせ
JP2005534634A (ja) 治療方法
US20070021329A1 (en) Treatment of hypersensitivity conditions
JP2006514015A5 (cg-RX-API-DMAC7.html)
CN108367052A (zh) 用于治疗组织损伤的药物组合物
WO2004003007A1 (fr) Peptides se liant a des cellules non lymphocytaires, et utilisations correspondantes
Ortega Organ transplantation in the 21th century
CN101919832A (zh) 高级脂肪酸衍生物的免疫抑制剂及其应用
ES2269825T3 (es) Composicion y procedimiento para el tratamiento del rechazo de aloinjerto.
Csapo et al. The Impact of the Discovery of Cyclosporine on Transplantation of Composite Tissue Allografts